ECP 2022 Final Programme

Poster Sessions a Sunday 80 Sunday, 4 Sept PS-01 e Sunday, 4 September 2022 PS-01 Poster Session Poster Session Breast Pathology Chairs: Cecily Quinn, Ireland Giuseppe Floris, Belgium 001 Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future perspectives Tomonori Kawasaki, Japan T. Tashima, Y. Nakamura, A. Fujimoto, Y. Usami, A. Fujita, H. Imai, Y. Baba, M. Nakahira, S. Ryozawa, K. Okamoto, H. Kagamu, T. Inozume, C. Muramatsu, M. Saitoh, K. Taniyama, H. Nagai, T. Kondo, A. Enomoto, K. Kaira 002 PRAME expression in invasive breast carcinoma Lea Korša, Croatia M. Abramovic, T. Pikivaca, L. Kovačević, M. Milošević, M. Prutki, Z. Marušić 003 Alpha-methylacyl-CoA Racemase (AMACR/P504S) over-expression occurs in the early proliferative lesions of the breast irrespective of apocrine differentia- tion Semir Vranic, Qatar Z. Gatalica, P. Stafford 004 Evaluation of NLRP3 immunohistochemi- cal levels in breast cancer Maria Lambropoulou, Greece V. Papadatou, A. Karatza, S. Tologkos, T. Deftereou, V. Lampropoulou, T. Alexiadis, I. Olbasalis, C. Alexiadi, T. ChatzIneophytou, G. Tripsianis, O. Pagonopoulou 005 Encapsulated papillary carcinoma. Our experience from 2005 Alicia Córdoba, Spain R. Beloqui, I. Fernandez, C. Cerezo, A. Pasco, M. Mercado, I. Amat 006 Applicability of One Step Nucleic Acid in cytokeratin 19 negative tumours, based on a series of cases Alicia Córdoba, Spain M. Bronte, I. Fernandez, I. Amat, R. Beloqui, A. Larrea 007 Gross examination of post neoadjuvant chemotherapy (NACT) breast resections in resource constraint setting – how much is enough? Prarthna Shah, India S. Desai, T. Shet 008 Clinicopathological features and response to neoadjuvant chemotherapy in triple positive breast cancer Amen Dhaoui, Tunisia Y. Houcine, K. Hamza, S. Kammoun, G. Sahraoui, S. Ayadi, R. Chargui, M. Driss 009 MMP-2 expression in BC and its association with clinicopathological features and lymph nodes status Vlada Kometova, Russia L. Mikhaleva, V. Rodionov, I. Kolyadina, M. Dardyk, M. Rodionova 010 Sentinel lymph node localization with Magtrace. Our experience so far Efthymios Koniaris, Greece E. Panopoulou, A. Stylianaki, G. Zografos, G. Kafiri 011 FOXA1 and lymph nodes status in breast cancer Vlada Kometova, Russia V. Rodionov, I. Kolyadina, M. Rodionova, M. Dardyk, L. Mikhaleva 012 SLC7A5 expression in breast cancer and its association with molecular subtypes Vlada Kometova, Russia I. Kolyadina, L. Mikhaleva, M. Rodionova, M. Dardyk, V. Rodionov